Clinical Trial Update: A Phase 2 Study of HX301 in Patients with High-grade Giloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study of HX301 for high-grade glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• HX301

Snippet

Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. | Conditions: Glioma | Phase 1, Phase 2 | Status: RECRUITING